These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9331805)

  • 1. Role of complement and complement receptor C1qR in the antibody-independent killing of group B streptococcus.
    Butko P; Nicholson-Weller A; Wessels MR
    Adv Exp Med Biol; 1997; 418():941-3. PubMed ID: 9331805
    [No Abstract]   [Full Text] [Related]  

  • 2. Bactericidal activity elicited by the beta C protein of group B streptococci contrasted with capsular polysaccharides.
    Fusco PC; Perry JW; Liang SM; Blake MS; Michon F; Tai JY
    Adv Exp Med Biol; 1997; 418():841-5. PubMed ID: 9331784
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of C5a and tumor necrosis factor-alpha on phagocytosis of Streptococcus agalactiae NT/X and IV/X by bovine neutrophils.
    Rainard P; Poutrel B
    Adv Exp Med Biol; 1997; 418():953-5. PubMed ID: 9331808
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.
    Baker CJ; Edwards MS; Webb BJ; Kasper DL
    J Clin Invest; 1982 Feb; 69(2):394-404. PubMed ID: 7035495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
    Butko P; Nicholson-Weller A; Wessels MR
    J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opsonization of Streptococcus agalactiae of bovine origin by complement and antibodies against group B polysaccharide.
    Rainard P; Boulard C
    Infect Immun; 1992 Nov; 60(11):4801-8. PubMed ID: 1398991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of complement in opsonization of GBS.
    Edwards MS; Kasper DL; Nicholson-Weller A; Baker CJ
    Antibiot Chemother (1971); 1985; 35():170-89. PubMed ID: 3901894
    [No Abstract]   [Full Text] [Related]  

  • 8. Binding of surfactant protein A to C1q receptors mediates phagocytosis of Staphylococcus aureus by monocytes.
    Geertsma MF; Nibbering PH; Haagsman HP; Daha MR; van Furth R
    Am J Physiol; 1994 Nov; 267(5 Pt 1):L578-84. PubMed ID: 7977768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of in vitro opsonic activity of human antibody induced by a vaccine consisting of the type III-specific polysaccharide of group B streptococcus.
    De Cueninck BJ; Eisenstein TK; McIntosh TS; Shockman GD; Swenson RM
    Infect Immun; 1983 Mar; 39(3):1155-60. PubMed ID: 6341229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q.
    Webster SD; Galvan MD; Ferran E; Garzon-Rodriguez W; Glabe CG; Tenner AJ
    J Immunol; 2001 Jun; 166(12):7496-503. PubMed ID: 11390503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.
    Payne NR; Kim YK; Ferrieri P
    Infect Immun; 1987 May; 55(5):1243-51. PubMed ID: 3552996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fluorescence-based opsonophagocytosis assay to measure the functional activity of antibody to group B Streptococcus.
    Guttormsen HK; Mascuch SJ; West JC; Paoletti LC
    Hum Vaccin; 2009 Jul; 5(7):461-6. PubMed ID: 19377284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement in neonatal infections: an overview.
    Edwards MS
    Pediatr Infect Dis; 1986; 5(3 Suppl):S168-70. PubMed ID: 3520500
    [No Abstract]   [Full Text] [Related]  

  • 14. cDNA cloning and primary structure analysis of C1qR(P), the human C1q/MBL/SPA receptor that mediates enhanced phagocytosis in vitro.
    Nepomuceno RR; Henschen-Edman AH; Burgess WH; Tenner AJ
    Immunity; 1997 Feb; 6(2):119-29. PubMed ID: 9047234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of complement activation on platelets.
    Devine DV
    Curr Top Microbiol Immunol; 1992; 178():101-13. PubMed ID: 1330445
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of specific antibody in alternative complement pathway-mediated opsonophagocytosis of type III, group B Streptococcus.
    Edwards MS; Nicholson-Weller A; Baker CJ; Kasper DL
    J Exp Med; 1980 May; 151(5):1275-87. PubMed ID: 6989947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a multiplexed opsonophagocytic killing assay (MOPA) for group B Streptococcus.
    Choi MJ; Noh JY; Cheong HJ; Kim WJ; Lin SM; Zhi Y; Lim JH; Lim S; Seo HS; Song JY
    Hum Vaccin Immunother; 2018 Jan; 14(1):67-73. PubMed ID: 28933634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the classical pathway of complement by binding of bovine lactoferrin to unencapsulated Streptococcus agalactiae.
    Rainard P
    Immunology; 1993 Aug; 79(4):648-52. PubMed ID: 8406591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group-B streptococcus--profile of an organism.
    Ross PW
    J Med Microbiol; 1984 Oct; 18(2):139-66. PubMed ID: 6387125
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of complement in inflammation and bacterial killing.
    Späth PJ
    Curr Stud Hematol Blood Transfus; 1992; (59):100-45. PubMed ID: 1572211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.